Section 12-6A-01 - Definitions(a) In this subtitle the following words have the meanings indicated.(b) "Authorized prescriber" means a licensed physician, licensed podiatrist, or certified advanced practice nurse with prescriptive authority under § 8-508 of this article.(c) "Group model health maintenance organization" has the meaning stated in § 19-713.6 of the Health - General Article.(d) "Health maintenance organization" has the meaning stated in § 19-701(g) of the Health - General Article.(e)(1) "Institutional facility" means a facility other than a nursing home whose primary purpose is to provide a physical environment for patients to obtain inpatient or emergency care.(2) "Institutional facility" does not include an urgent care facility that is not part of a facility.(f) "Prescriber-pharmacist agreement" means an agreement between an authorized prescriber and a licensed pharmacist that is disease-state specific and specifies the protocols that may be used.(g) "Protocol" means a course of treatment predetermined by the authorized prescriber and licensed pharmacist according to generally accepted medical practice for the proper completion of a particular therapeutic or diagnostic intervention.(h) "Therapy management contract" means a voluntary arrangement that is:(1) Disease-state specific;(2) Agreed on by:(i) One licensed pharmacist and the licensed pharmacist's designated alternate licensed pharmacists;(ii) One authorized prescriber and alternate designated authorized prescribers involved directly in patient care; and(iii) One patient receiving care from an authorized prescriber and a licensed pharmacist pursuant to a prescriber-pharmacist agreement and protocol under this subtitle; and(3) Related to treatment using drug therapy, laboratory tests, or medical devices, under defined conditions or limitations for the purpose of improving patient outcomes.Amended by 2023 Md. Laws, Ch. 399, Sec. 1, eff. 10/1/2023.Amended by 2015 Md. Laws, Ch. 269, Sec. 1, eff. 10/1/2015.